Severance Hospital, Yonsei University Health System

Site:	Severance Hospital, Yonsei University Health System
Address:
City:	Seoul
State:
Zip:
Country:	Republic of Korea

Phase	Trial [asc]	Trial Status	Site Status	Drug	NCT#
2	Study of LOXO-101 in Subjects With NTRK Fusion Positive Solid Tumors	Active, not recruiting	Active	LOXO-101	NCT02576431
3	(VOYAGER) Study of Avapritinib vs Regorafenib in Patients With Locally Advanced Unresectable or Metastatic GIST	Active, not recruiting	Active	Avapritinib or Regorafenib	NCT03465722